MRKR: Marker Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 39.65
Enterprise Value ($M) 24.53
Book Value ($M) 14.05
Book Value / Share 1.58
Price / Book 2.82
NCAV ($M) 14.05
NCAV / Share 1.58
Price / NCAV 2.82

Profitability (mra)
Return on Invested Capital (ROIC) -0.59
Return on Assets (ROA) -0.24
Return on Equity (ROE) -0.42

Liquidity (mrq)
Quick Ratio 5.57
Current Ratio 5.57

Balance Sheet (mrq) ($M)
Current Assets 17.13
Assets 17.13
Liabilities 3.07
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.31
Operating Income -14.58
Net Income -8.24
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -16.44
Cash from Investing 18.66
Cash from Financing 1.11

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2023-03-03 13D/A Aisling Capital IV, LP 5.46 -86.73

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 1,348 19,494 6.91
2024-03-27 1,300 15,856 8.20
2024-03-26 5,466 45,149 12.11
2024-03-25 1,534 10,955 14.00

(click for more detail)

Similar Companies
MIRA – MIRA Pharmaceuticals, Inc. MLTX – MoonLake Immunotherapeutics
MNPR – Monopar Therapeutics Inc. MTEM – Molecular Templates, Inc.
MYMD – MyMD Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io